MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
166 hedge funds and large institutions have $1.05B invested in Momenta Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 68 increasing their positions, 44 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
+8
Holders Change %
+5.06%
% of All Funds
3.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
68
Reduced
44
Closed
18
Calls
$3.76M
Puts
$2.59M
Net Calls
+$1.17M
Net Calls Change
-$1.84M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.3M |
| 2 |
Millennium Management
New York
|
+$10.7M |
| 3 |
TAM
Tocqueville Asset Management
New York
|
+$9.53M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.47M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.21M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$13.7M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$9.25M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$8.67M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$6.91M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$6.57M |
